Furthermore, CLDN3 and CLDN4 impeded EMT in ovarian carcinoma through the activation of the PI3K/Akt pathway [84], in line with CLDN7-mediated inhibition of cell migration and invasion through the ERK/MAPK signaling pathway in human lung cancer cells [85]. This evidence concerns the gene CLDN4 and ovarian carcinoma.